Sex-based antibody subclass maturation drives direct enzymatic inhibition in fabry disease patients receiving enzyme replacement therapy基于性别的抗体亚类成熟驱动法布雷病患者在接受酶替代疗法时的直接酶抑制。Frontiers in Molecular BiosciencesIF42026-04-090OAAI
Stroke in Fabry Disease: Identification of Risk Factors for Stroke in a Large Single-Centre Cohort法布里病中的卒中:识别大型单中心队列中卒中的危险因素European Journal of NeurologyIF3.92025-11-070OAAI
Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI studyNEUROBIOLOGY OF DISEASEIF5.62023-11-016OAAI
Clinical features and health-related quality of life in adult patients with mucopolysaccharidosis IVA: the Spanish experienceORPHANET JOURNAL OF RARE DISEASESIF3.52021-11-0310OAAI
Biomarkers in Fabry Disease. Implications for Clinical Diagnosis and Follow-upJOURNAL OF CLINICAL MEDICINEIF2.92021-04-1321OAAI
Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensusMOLECULAR GENETICS AND METABOLISMIF3.52021-04-019OAAI
Stroke characterisation and description of identified risk factors in a Fabry disease large cohortMOLECULAR GENETICS AND METABOLISMIF3.52020-02-010PREAI
Chronic immune thrombocytopenia refractory to treatment in a patient with Gaucher disease with a common genotypeMOLECULAR GENETICS AND METABOLISMIF3.52020-02-010PREAI
Amyloid deposition in a patient with the complex Gaucher disease/Parkinson diseaseMOLECULAR GENETICS AND METABOLISMIF3.52020-02-010PREAI